Literature DB >> 17659184

An update on the amyloid hypothesis.

Christopher B Eckman1, Elizabeth A Eckman.   

Abstract

Alzheimer's disease (AD) is a devastating neurodegenerative disease. To rationally develop novel therapeutic and/or preventative agents for AD, an understanding of the etiology and pathogenesis of this complex disease is necessary. This article examines the evidence for the amyloid hypothesis of AD pathogenesis and discusses how it relates to the neurological and neuropathological features of AD, the known genetic risk factors and causative mutations, and the heightened risk associated with advanced age.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659184      PMCID: PMC2857315          DOI: 10.1016/j.ncl.2007.03.007

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  75 in total

Review 1.  The genetics of Alzheimer disease: current status and future prospects.

Authors:  D Blacker; R E Tanzi
Journal:  Arch Neurol       Date:  1998-03

2.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

3.  Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.

Authors:  M S Wolfe; W Xia; B L Ostaszewski; T S Diehl; W T Kimberly; D J Selkoe
Journal:  Nature       Date:  1999-04-08       Impact factor: 49.962

4.  Alzheimer neuropathologic alterations in aged cognitively normal subjects.

Authors:  D G Davis; F A Schmitt; D R Wekstein; W R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  1999-04       Impact factor: 3.685

5.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.

Authors:  A Y Hsia; E Masliah; L McConlogue; G Q Yu; G Tatsuno; K Hu; D Kholodenko; R C Malenka; R A Nicoll; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

Authors:  L F Lue; Y M Kuo; A E Roher; L Brachova; Y Shen; L Sue; T Beach; J H Kurth; R E Rydel; J Rogers
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

7.  The case described by Alois Alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sections.

Authors:  H J Möller; M B Graeber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1998       Impact factor: 5.270

8.  Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease.

Authors:  H Funato; M Yoshimura; K Kusui; A Tamaoka; K Ishikawa; N Ohkoshi; K Namekata; R Okeda; Y Ihara
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

Review 9.  Alzheimer's disease: genetic studies and transgenic models.

Authors:  D L Price; R E Tanzi; D R Borchelt; S S Sisodia
Journal:  Annu Rev Genet       Date:  1998       Impact factor: 16.830

10.  Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity.

Authors:  C Geula; C K Wu; D Saroff; A Lorenzo; M Yuan; B A Yankner
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

View more
  14 in total

1.  Nantenine as an acetylcholinesterase inhibitor: SAR, enzyme kinetics and molecular modeling investigations.

Authors:  Stevan Pecic; Marie A McAnuff; Wayne W Harding
Journal:  J Enzyme Inhib Med Chem       Date:  2010-06-28       Impact factor: 5.051

2.  Is cerebral microbleed prevalence relevant as a biomarker in amnestic mild cognitive impairment and mild Alzheimer's disease?

Authors:  Ana Gb Rabelo; Camila Vl Teixeira; Thamires Nc Magalhães; Ana Flávia Mk Carletti-Cassani; Augusto Cs Amato Filho; Helena Pg Joaquim; Leda L Talib; Orestes Forlenza; Patrícia Ao Ribeiro; Rodrigo Secolin; Iscia Lopes-Cendes; Fernando Cendes; Marcio Lf Balthazar
Journal:  Neuroradiol J       Date:  2017-07-17

Review 3.  Stem cell technology for neurodegenerative diseases.

Authors:  J Simon Lunn; Stacey A Sakowski; Junguk Hur; Eva L Feldman
Journal:  Ann Neurol       Date:  2011-09       Impact factor: 10.422

4.  Microglial P2X₇ receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe/PS1dE9 mouse model of Alzheimer's disease.

Authors:  Hwan Goo Lee; Sun Mi Won; Byoung Joo Gwag; Yong Beom Lee
Journal:  Exp Mol Med       Date:  2011-01-31       Impact factor: 8.718

Review 5.  Progress in stem cell therapy for major human neurological disorders.

Authors:  P L Martínez-Morales; A Revilla; I Ocaña; C González; P Sainz; D McGuire; I Liste
Journal:  Stem Cell Rev Rep       Date:  2013-10       Impact factor: 5.739

Review 6.  Behavior of neural stem cells in the Alzheimer brain.

Authors:  B Waldau; A K Shetty
Journal:  Cell Mol Life Sci       Date:  2008-08       Impact factor: 9.261

Review 7.  Amyloid beta: multiple mechanisms of toxicity and only some protective effects?

Authors:  Paul Carrillo-Mora; Rogelio Luna; Laura Colín-Barenque
Journal:  Oxid Med Cell Longev       Date:  2014-02-05       Impact factor: 6.543

8.  Insights into the fate of the N-terminal amyloidogenic polypeptide of ApoA-I in cultured target cells.

Authors:  Angela Arciello; Nadia De Marco; Rita Del Giudice; Fulvio Guglielmi; Piero Pucci; Annalisa Relini; Daria Maria Monti; Renata Piccoli
Journal:  J Cell Mol Med       Date:  2011-12       Impact factor: 5.310

Review 9.  NADPH oxidase as a therapeutic target in Alzheimer's disease.

Authors:  Michelle L Block
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

10.  Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-I: A Novel Cellular Therapy for Alzheimer's Disease.

Authors:  Lisa M McGinley; Erika Sims; J Simon Lunn; Osama N Kashlan; Kevin S Chen; Elizabeth S Bruno; Crystal M Pacut; Tom Hazel; Karl Johe; Stacey A Sakowski; Eva L Feldman
Journal:  Stem Cells Transl Med       Date:  2016-01-07       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.